Edition:
United Kingdom

Bliss GVS Pharma Ltd (BLIS.NS)

BLIS.NS on National Stock Exchange of India

180.75INR
23 May 2018
Change (% chg)

Rs2.60 (+1.46%)
Prev Close
Rs178.15
Open
Rs177.95
Day's High
Rs182.50
Day's Low
Rs177.90
Volume
129,918
Avg. Vol
324,042
52-wk High
Rs220.25
52-wk Low
Rs129.15

Chart for

About

Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations. The Company offers a range of suppositories and pessaries catering to various therapeutic segments. The Company's suppositories products include Anti-Malarial, Anti-Haemorrhoidal, Anti-Spasmodic, Laxatives, Anti-Inflammato... (more)
No analyst recommendations are available for .

Overall

Beta: 0.61
Market Cap(Mil.): Rs16,219.81
Shares Outstanding(Mil.): 103.15
Dividend: 0.60
Yield (%): 0.38

Financials

  BLIS.NS Industry Sector
P/E (TTM): 15.94 30.95 32.75
EPS (TTM): 9.87 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Bliss GVS Pharma Says Unit Kremoint Pharma Acquires 60 Pct Stake In Eco—Rich Cosmetic India

* SAYS UNIT KREMOINT PHARMA PRIVATE LTD ACQUIRED 60 PERCENT STAKE IN ECO—RICH COSMETIC INDIA PRIVATE LTD Source text for Eikon: Further company coverage:

20 Apr 2018

BRIEF-Bliss GVS Pharma Gets $12 Mln For Sale Of Shares Of Kenya Unit

* GETS $12 MILLION FOR SALE OF SHARES OF BLISS GVS HEALTHCARE LTD, KENYA FROM MAYFAIR HEALTHCARE HOLDINGS LTD Source text - https://bit.ly/2GYjoru Further company coverage:

13 Apr 2018

BRIEF-Bliss GVS Pharma Seeks Shareholders' Nod To Disinvest Step Down Unit

* SEEKS SHAREHOLDERS' NOD TO DISINVEST STEP DOWN UNIT BLISS GVS HEALTHCARE, NAIROBI Source text - http://bit.ly/2s1pFQ5 Further company coverage:

02 Feb 2018

Earnings vs. Estimates